Current Pharmaceutical Design
ISSN (Print):
1381-6128
ISSN (Online):
1873-4286
Download PDF Flyer

Current Pharmaceutical Design

All Open Access articles of this journal are also available on ScienceDirect.

Impact Factor: 2.8

Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed... View all

Volume 32 , Issues 42, 2026


Institutional Members

Volume 32, Issue 20


Review Article

Steatotic Shadows: The Dark Link Between Metabolic Dysfunction-associated Steatotic Liver Disease and Cancer Risk

Pp: 1539-1551
Author(s): Shakta Mani Satyam, Mohamed El-Tanani*, Syed Arman Rabbani, Alaa A. Aljabali, Yahia El-Tanani, Dimitrios Patoulias and Manfredi Rizzo
DOI: 10.2174/0113816128366825250307043756

Review Article

FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data

Pp: 1552-1566
Author(s): Chrysoula Boutari, Achilleas Triantafyllou, Lavrentis Papalavrentios, Ioannis Goulis and Emmanouil Sinakos*
DOI: 10.2174/0113816128374854250709050425

Review Article

Incretin-based Agents and Metabolic Dysfunction-associated Steatotic Liver Disease

Pp: 1567-1591
Author(s): Emir Muzurović*, Martin Haluzik, Ludek Horváth, Bogdan Vlacho and Didac Mauricio
DOI: 10.2174/0113816128378484250619080753

Research Article

Nutraceutical Synergy: Unraveling the Protective Effects of Methyl Gallate and Chia Seed Oil in Doxorubicin-induced Hepatic Injury and Bax/Bcl2 Imbalance

Pp: 1592-1604
Author(s): Shakta Mani Satyam, Mohamed El-Tanani, Akheruz Zaman Ahmed, Manfredi Rizzo, Dimitrios Patoulias, Prakashchandra Shetty Kanyana*, Kalyan Chakravarthi Kosuri, Rashmi Kumari and Sainath Prabhakar
DOI: 10.2174/0113816128366802250413160625

Mini-Review Article

Multi-Endogenous Nanoformulation for Endocannabinoid and Hormonal Modulation of Key Signaling Pathways in Resistant Hypertension

Pp: 1605-1611
Author(s): Virna Margarita Martín Giménez, Sebastián García Menéndez and Walter Manucha*
DOI: 10.2174/0113816128396666250728074858